News
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are
The National Cancer Institute is currently soliciting proposals for two contract funding opportunities in cancer technologies through the SBIR-TT Program. Details on each proposal may be found by clicking on the individual Contract Topics below. NCI SBIR Contract Topic 317 — Wound Healing
A new website is now available to find technologies related to rare diseases or conditions across 30 of the Clinical Translation Science Award (CTSA) institutions and NIH. The CTSA institutions are funded by NIH as part of a program designed to spur the transformation of clinical and translational
The Office of Intramural Research, Office of the Director, NIH, invites you to the seventh annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer. The lecture will be held on Thursday, November 15, 2012, at 10:00 AM in the Masur Auditorium, Building 10, NIH